303 related articles for article (PubMed ID: 38612708)
21. Complex interactions in Parkinson's disease: a two-phased approach.
Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
[TBL] [Abstract][Full Text] [Related]
22. Genetics of Parkinson's disease.
Gasser T
J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
[TBL] [Abstract][Full Text] [Related]
23. Association Between Parkinson's Disease and Melanoma: Putting the Pieces Together.
Ye Q; Wen Y; Al-Kuwari N; Chen X
Front Aging Neurosci; 2020; 12():60. PubMed ID: 32210791
[TBL] [Abstract][Full Text] [Related]
24. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.
Conway JA; Kinsman G; Kramer ER
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328067
[TBL] [Abstract][Full Text] [Related]
25. Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender.
Lee JYS; Ng JH; Saffari SE; Tan EK
Aging (Albany NY); 2022 Mar; 14(5):2148-2173. PubMed ID: 35247252
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
27. Skin cancer and Parkinson's disease.
Ferreira JJ; Neutel D; Mestre T; Coelho M; Rosa MM; Rascol O; Sampaio C
Mov Disord; 2010 Jan; 25(2):139-48. PubMed ID: 20063399
[TBL] [Abstract][Full Text] [Related]
28. Overlapping genetic architecture between Parkinson disease and melanoma.
Dube U; Ibanez L; Budde JP; Benitez BA; Davis AA; Harari O; Iles MM; Law MH; Brown KM; ; ; Cruchaga C
Acta Neuropathol; 2020 Feb; 139(2):347-364. PubMed ID: 31845298
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's Disease: Assay of Phosphorylated α-Synuclein in Skin Biopsy for Early Diagnosis and Association with Melanoma.
Surguchov A
Brain Sci; 2016 May; 6(2):. PubMed ID: 27240409
[TBL] [Abstract][Full Text] [Related]
30. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
32. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
33. Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.
Zhang X; Guarin D; Mohammadzadehhonarvar N; Chen X; Gao X
BMJ Open; 2021 Jul; 11(7):e046329. PubMed ID: 34215604
[TBL] [Abstract][Full Text] [Related]
34. Unravelling the genetic links between Parkinson's disease and lung cancer.
Leong YQ; Koh RY; Chye SM; Ng KY
Biol Chem; 2023 May; 404(6):551-567. PubMed ID: 36634094
[TBL] [Abstract][Full Text] [Related]
35. Autosomal dominant Parkinson's disease and alpha-synuclein.
Polymeropoulos MH
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S63-4. PubMed ID: 9749575
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
[TBL] [Abstract][Full Text] [Related]
37. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
38. New insights into Parkinson's disease.
Chung KK; Dawson VL; Dawson TM
J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
[TBL] [Abstract][Full Text] [Related]
39. Cancer and Parkinson's disease: the odd couple.
Gao X; Ning Y
Drugs Today (Barc); 2011 Mar; 47(3):215-22. PubMed ID: 21494699
[TBL] [Abstract][Full Text] [Related]
40. Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.
Mack JM; Schamne MG; Sampaio TB; Pértile RA; Fernandes PA; Markus RP; Prediger RD
Oxid Med Cell Longev; 2016; 2016():3472032. PubMed ID: 27829983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
